Stocksigma LogoStocksigma Logo

Indoco Remedies Receives Seven USFDA Observations for Goa Sterile Facility

Indoco Remedies received seven Form 483 observations following a USFDA inspection of its sterile manufacturing facility at Plant II in Goa, conducted

Indoco Remedies Receives Seven USFDA Observations for Goa Sterile Facility

Indoco Remedies Ltd 路 Others (Uncategorized) 路 05 Sept 2026, 7:11 pm

Indoco Remedies Receives Seven USFDA Observations for Goa Sterile Facility Indoco Remedies received seven Form 483 observations following a USFDA inspection of its sterile manufacturing facility at Plant II in Goa, conducted between 27th Aug'26 and 4th Sep'26. The company stated it is addressing the observations comprehensively and plans to submit its response to the regulator within the stipulated timeframe.

Original exchange filing (PDF)

More announcements from Indoco Remedies Ltd

All Indoco Remedies Ltd announcements